In the last trading session, 1.06 million shares of the NRX Pharmaceuticals Inc (NASDAQ:NRXP) were traded, and its beta was 1.07. Most recently the company’s share price was $4.01, and it changed around -$0.25 or -5.87% from the last close, which brings the market valuation of the company to $48.50M. NRXP currently trades at a discount to its 52-week high of $7.33, offering almost -82.79% off that amount. The share price’s 52-week low was $1.10, which indicates that the current value has risen by an impressive 72.57% since then. We note from NRX Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 2.67 million shares, with the 3-month average coming to 1.04 million.
NRX Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended NRXP as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. NRX Pharmaceuticals Inc is expected to report earnings per share of -0.29 for the current quarter.
NRX Pharmaceuticals Inc (NASDAQ:NRXP) trade information
Instantly NRXP has showed a red trend with a performance of -5.87% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 6.01 on recent trading dayincreased the stock’s daily price by 33.28%. The company’s shares are currently up 82.27% year-to-date, but still down -17.32% over the last five days. On the other hand, NRX Pharmaceuticals Inc (NASDAQ:NRXP) is 234.17% up in the 30-day period. We can see from the shorts that 0.68 million shares have been sold at a short interest cover period of 4.8 day(s).
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to decrease their stock price by -100.5% from its current value. Analyst projections state that NRXP is forecast to be at a low of $2 and a high of $2.
NRX Pharmaceuticals Inc (NRXP) estimates and forecasts
NRX Pharmaceuticals Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 72.10 percent over the past six months and at a 52.70% annual growth rate that is well above the industry average of 16.60%.
1 analysts expect NRX Pharmaceuticals Inc to make 5M in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at 0.00%.
NRXP Dividends
NRX Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in February.
NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 23.56% of NRX Pharmaceuticals Inc shares, and 6.05% of them are in the hands of institutional investors. The stock currently has a share float of 7.92%.
AdvisorShares Trust-AdvisorShares Psychedelics ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Nov 30, 2024 . The former held 318.5 shares worth $1.28 million, making up 2.63% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 193.42 shares worth around $0.78 million, which represents about 1.60% of the total shares outstanding.
